Banda Nirmal K, Wood Allyson K, Takahashi Kazue, Levitt Brandt, Rudd Pauline M, Royle Louise, Abrahams Jodie L, Stahl Gregory L, Holers V Michael, Arend William P
Division of Rheumatology, University of Colorado Denver, School of Medicine, Aurora, CO 80045, USA.
Arthritis Rheum. 2008 Oct;58(10):3081-9. doi: 10.1002/art.23865.
Collagen antibody-induced arthritis in mice exhibits a requirement for amplification by the alternative pathway of complement. Although the alternative pathway is activated by spontaneous hydrolysis, it is not known whether this pathway can also be initiated directly by IgG antibodies in immune complexes (ICs). IgG lacking terminal sialic acid and galactose (G0 IgG) can activate the lectin pathway of complement, but it is not known if G0 IgG can also activate the classical or alternative pathway. The purpose of this study was to examine the mechanism of initiation of the alternative pathway of complement by ICs.
We used adherent ICs containing bovine type II collagen (CII) and 4 monoclonal antibodies (mAb) to CII (adCII-IC). C3 activation was measured in the presence of sera from wild-type C57BL/6 mice or from mice deficient in informative complement components. The mAb were used intact or after enzyme digestion to create G0 IgG or to completely remove the N-glycan.
Both the classical and alternative pathways, but not the lectin pathway, mediated C3 activation induced by the adCII-IC. Mannose inhibited the alternative pathway-mediated C3 activation but had no effect on the classical pathway, and N-glycans in IgG were required by the alternative pathway but not the classical pathway. Both the classical and alternative pathways mediated C3 activation induced by G0 IgG. Mannose-binding lectin bound avidly to G0 IgG, but lectin pathway-mediated C3 activation was only slightly increased by G0 IgG.
The alternative pathway of complement is capable of initiating C3 activation induced by adCII-IC and requires the presence of N-glycans on the IgG. G0 IgG activates both the classical and alternative pathways more strongly than the lectin pathway.
小鼠胶原抗体诱导的关节炎表现出对补体替代途径放大作用的需求。尽管替代途径可通过自发水解激活,但尚不清楚该途径是否也能由免疫复合物(ICs)中的IgG抗体直接启动。缺乏末端唾液酸和半乳糖的IgG(G0 IgG)可激活补体凝集素途径,但尚不清楚G0 IgG是否也能激活经典途径或替代途径。本研究的目的是探讨ICs启动补体替代途径的机制。
我们使用含有牛II型胶原(CII)和4种抗CII单克隆抗体(mAb)的黏附性ICs(adCII-IC)。在野生型C57BL/6小鼠或缺乏相关补体成分的小鼠血清存在的情况下测量C3激活。mAb完整使用或经酶消化后产生G0 IgG或完全去除N-聚糖。
经典途径和替代途径而非凝集素途径介导了adCII-IC诱导的C3激活。甘露糖抑制替代途径介导的C3激活,但对经典途径无影响,替代途径需要IgG中的N-聚糖而经典途径不需要。经典途径和替代途径均介导了G0 IgG诱导的C3激活。甘露糖结合凝集素与G0 IgG avidly结合,但G0 IgG仅轻微增加凝集素途径介导的C3激活。
补体替代途径能够启动adCII-IC诱导的C3激活,并且需要IgG上存在N-聚糖。G0 IgG激活经典途径和替代途径的能力比凝集素途径更强。